LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh ...
Read more
(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray ...
Read more
LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end.Companies ...
Read more
LOS ANGELES (Reuters) - Toxicity caused by debris from a metal-on-metal hip implant meant that the device had to be removed from a 66-year-old man who is suing manufacturer Johnson ...
Read more
Los Angeles (Reuters) - Johnson & Johnson was aware of defects when it started selling its now-recalled metal hip implants in 2004, lawyers said on Friday during opening arguments in ...
Read more
(Reuters) - They may be difficult to pronounce, but pharmaceutical companies eager to grab the attention of doctors and patients are returning to drug names starting with X and Z.Recent ...
Read more
November 15, 2012 9:30 am by DEENA BEASLEY, | 0 Comments
Johnson & Johnson, Merck & Co Inc and Eli Lily & Co, plan to launch a one-stop database of global clinical trial sites aimed at streamlining paperwork and speeding the ...
Read more
November 12, 2012 2:12 pm by DEENA BEASLEY, | 0 Comments
LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer.Record prices for drugs ...
Read more
(Reuters) - Stem cells culled from the bone marrow of healthy donors work as well or even better as cells harvested from patients themselves as a treatment for damaged hearts ...
Read more
LOS ANGELES (Reuters) - Amgen Inc's experimental drug AMG145 reduced levels of bad cholesterol by as much as 55 percent in combination with statin drugs in patients genetically predisposed to ...
Read more
November 4, 2012 10:05 pm by DEENA BEASLEY, | 0 Comments
LOS ANGELES (Reuters) - Angioplasty to clear blocked arteries costs more at hospitals not equipped for emergency heart surgery, according to a study presented on Sunday at the American Heart ...
Read more
LOS ANGELES (Reuters) - A controversial therapy to remove heavy metals from the bloodstream was shown in a large trial to cut the risk of another major heart problem in ...
Read more
LOS ANGELES/NEW YORK (Reuters) - A controversial treatment for multiple sclerosis has been linked by U.S. health regulators to serious injuries including stroke, paralysis or even death, prompting them to ...
Read more
September 9, 2012 1:17 pm by DEENA BEASLEY, | 1 Comments
LOS ANGELES (Reuters) - The first preventive pill for HIV has been hailed as a landmark in the fight against AIDS in the United States, but experts say only a ...
Read more
(Reuters) - A novel prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for men whose cancer has ...
Read more
